review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Mathis Heydtmann | |
P2860 | cites work | Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver | Q71636651 |
Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms | Q72075544 | ||
Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma | Q72680200 | ||
Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis | Q79367338 | ||
Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis | Q80088072 | ||
Interleukin-10 and the interleukin-10 receptor | Q24290912 | ||
Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses | Q24300398 | ||
Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines | Q24310415 | ||
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway | Q24336138 | ||
Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma | Q24563988 | ||
Transmission of human hepatitis C virus from patients in secondary cells for long term culture | Q24800686 | ||
Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein | Q24814742 | ||
Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response | Q27469808 | ||
Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 | ||
Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection | Q27487395 | ||
Alternative activation of macrophages | Q27860939 | ||
Local control of the immune response in the liver | Q28144211 | ||
M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
Monocyte and macrophage heterogeneity | Q29547438 | ||
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 | ||
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
Type I interferons in host defense | Q29615912 | ||
The many faces of macrophage activation | Q29617449 | ||
Immunology of hepatitis B virus and hepatitis C virus infection | Q29618957 | ||
Adaptive immune responses in acute and chronic hepatitis C virus infection | Q29619722 | ||
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
Kupffer cell-dependent hepatitis occurs during influenza infection | Q30445136 | ||
Emerging evidence of hepatitis C virus neuroinvasion | Q31013540 | ||
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair | Q33565774 | ||
Genomic analysis of the host response to hepatitis B virus infection | Q33696514 | ||
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. | Q33788761 | ||
Innate defenses in the liver during Listeria infection | Q33916613 | ||
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease | Q34112417 | ||
Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study | Q34224706 | ||
Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma | Q34261766 | ||
Processing of engulfed apoptotic bodies yields T cell epitopes | Q34464645 | ||
Cytokines and chemokines in the immune response to hepatitis C infection | Q34608118 | ||
Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems. | Q34998262 | ||
Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection | Q35056266 | ||
Does nitric oxide play a pathogenic role in hepatitis C virus infection? | Q35091447 | ||
Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection | Q35358973 | ||
Regulation of macrophage activation | Q35587947 | ||
The liver: a model of organ-specific lymphocyte recruitment. | Q35677090 | ||
Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts | Q35749147 | ||
Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity | Q35763636 | ||
Multiple facets of macrophages in renal injury | Q35836435 | ||
Macrophage receptors and immune recognition | Q36072472 | ||
Liver immunobiology | Q36086411 | ||
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation | Q36231523 | ||
Recruitment of dendritic cells to pathological niches in inflamed liver | Q36260655 | ||
HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. | Q36308600 | ||
Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase | Q36369581 | ||
The conundrum of CD40 function: host protection or disease promotion? | Q36381645 | ||
The liver as an immunological organ | Q36382243 | ||
Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity | Q36423743 | ||
Cytokine and chemokine networks: pathways to antiviral defense | Q36434852 | ||
Toll-like receptor signaling in the liver | Q36477368 | ||
Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. | Q36511508 | ||
Role of Kupffer cells in host defense and liver disease | Q36653858 | ||
New insights into the regulation of liver inflammation and oxidative stress | Q36683811 | ||
Immunopathogenesis in hepatitis C virus cirrhosis | Q36697651 | ||
Subversion of innate host antiviral strategies by the hepatitis C virus | Q36805844 | ||
Innate immune response and hepatic inflammation | Q36989679 | ||
Immunobiology and pathogenesis of viral hepatitis | Q37014739 | ||
Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers | Q38347525 | ||
Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy | Q39603332 | ||
A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation. | Q40026040 | ||
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein | Q40190769 | ||
Nonstructural proteins 4A and 4B of hepatitis C virus transactivate the interleukin 8 promoter | Q40444001 | ||
Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation | Q40497000 | ||
Global expression analysis of extracellular matrix-integrin interactions in monocytes | Q40829599 | ||
Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages | Q40833771 | ||
Activated liver macrophages in human liver diseases | Q40962750 | ||
CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow | Q41086350 | ||
Effect of hepatitis B virus on tumour necrosis factor (TNF alpha) gene expression in human THP-1 monocytic and Namalwa B-cell lines. | Q41100345 | ||
Role of Kupffer cells in the pathogenesis of liver disease | Q42726018 | ||
Detection of hepatitis C virus RNA by in situ hybridization | Q42982224 | ||
Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. | Q42982462 | ||
Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C. | Q42984473 | ||
Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication. | Q42985967 | ||
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 | ||
Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology | Q42988418 | ||
HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients | Q42991314 | ||
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. | Q42993240 | ||
Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. | Q43033205 | ||
Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro | Q43033779 | ||
An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis | Q43038009 | ||
A study of susceptibility of primary human Kupffer cells to hepatitis C virus | Q43042430 | ||
Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis | Q43933354 | ||
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection | Q44445134 | ||
Chronic hepatitis C. Analysis of host immune response by immunohistochemistry | Q45233617 | ||
Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. | Q45424594 | ||
Toll-like receptor 3 promotes cross-priming to virus-infected cells. | Q45511446 | ||
Peritoneal macrophages suppress T-cell activation by amino acid catabolism | Q46942451 | ||
Hepatic allograft-derived Kupffer cells regulate T cell response in rats | Q47921693 | ||
Regulation of macrophage phenotype by long-term exposure to IL-10. | Q54643180 | ||
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice | Q57079491 | ||
Phenotypic Analysis of IL-10-Treated Macrophages Using the Monoclonal Antibodies RFD1 and RFD7 | Q61651915 | ||
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes | Q67901369 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis C | Q154869 |
macrophage | Q184204 | ||
Hepatitis C virus | Q708693 | ||
hepatitis B | Q6853 | ||
P304 | page(s) | 2796-2802 | |
P577 | publication date | 2008-10-08 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Macrophages in hepatitis B and hepatitis C virus infections | |
P478 | volume | 83 |
Q49620594 | 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. |
Q34169832 | A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease |
Q39060138 | Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. |
Q35896589 | Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes |
Q41559282 | Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination |
Q33584149 | Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients |
Q38157936 | Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations |
Q37522434 | Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation |
Q40358165 | Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes. |
Q40505663 | Evaluation of Gallium as a Tracer of Exogenous Hemoglobin-Haptoglobin Complexes for Targeted Drug Delivery Applications. |
Q38388423 | Extrahepatic manifestations in chronic hepatitis C virus carriers |
Q38077447 | HCV and oxidative stress in the liver. |
Q35988290 | HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes |
Q40947997 | HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production. |
Q41086980 | Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection. |
Q37296716 | Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-β |
Q37254259 | Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages. |
Q41530271 | Hepatitis C virus infection: a risk factor for Parkinson's disease |
Q40873258 | High post-treatment absolute monocyte count predicted hepatocellular carcinoma risk in HCV patients who failed peginterferon/ribavirin therapy |
Q33594263 | Identification of pro-inflammatory CD205+ macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B. |
Q28972246 | Immunosuppression abrogates resistance of young rabbits to Rabbit Haemorrhagic Disease (RHD) |
Q41020103 | Impaired monocyte-macrophage functions and defective Toll-like receptor signaling in hepatitis E virus-infected pregnant women with acute liver failure |
Q36335088 | Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection |
Q37098917 | Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (i |
Q27349825 | Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis |
Q59359816 | Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection |
Q89666166 | Macrophage Phenotype and Function in Liver Disorder |
Q33907429 | Molecular mechanisms of liver fibrosis in HIV/HCV coinfection |
Q33904328 | Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma |
Q58707869 | Polymorphisms in the Toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis B virus infection in Caucasian population |
Q42231930 | Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. |
Q38116098 | Suppression of interferon-mediated antiviral immunity by hepatitis B virus: an overview of research progress |
Q34539801 | TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection |
Q26774875 | The Role of Immune Cells in Chronic HBV Infection |
Q38129709 | The role of chemokines in acute and chronic hepatitis C infection |
Q30413135 | The role of macrophage polarization in infectious and inflammatory diseases |
Q40548291 | Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes |
Q62659541 | Upregulation of Toll-Like Receptors (TLRs) 6, 7, and 8 in Keloid Scars |
Q38181988 | Vaccine therapies for chronic hepatitis B: can we go further? |
Q90425663 | mTORC1-mediated polarization of M1 macrophages and their accumulation in the liver correlate with immunopathology in fatal ehrlichiosis |
Search more.